MOLINA ARTURO MD — SEC Form 4 filings
SEC reporting owner CIK 1398940. 12 Form 4 filings on record with FilingPulse; latest filed 2026-03-27.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-01-18 to 2026-03-27. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 15 legs across 9 filings — 137,966 shares, $8,810,527 total (shares × price as filed on priced legs).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 25.
- Largest priced transaction: sale of 30,514 shares @ $55.74 ($1,700,850) in Protagonist Therapeutics, Inc, filed 2025-03-14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | Chief Medical Officer | 12 | — | 15 legs · 137,966 sh · $8,810,527 | 25 |
Form 4 filings — MOLINA ARTURO MD
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-27 | 4 | Protagonist Therapeutics, Inc (PTGX) | Option exercise (M): 15,000 @ $8.04 · Sale (S): 15,000 @ $104.79 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2026-01-27 | 4 | Protagonist Therapeutics, Inc (PTGX) | Sale (S): 13,151 @ $82.42 · Option exercise (M): 5,000 @ $8.04 · Sale (S): 5,000 @ $82.28 · Option exercise (M): 5,000 @ $8.04 · Sale (S): 5,000 @ $82 · Option exercise (M): 5,000 (derivative) @ $0 · +1 more | EDGAR |
| 2026-01-21 | 4 | Protagonist Therapeutics, Inc (PTGX) | Sale (S): 9,514 @ $82.48 | EDGAR |
| 2026-01-06 | 4 | Protagonist Therapeutics, Inc (PTGX) | Grant/award (A): 25,600 @ $0 · Grant/award (A): 32,000 (derivative) @ $0 | EDGAR |
| 2025-11-19 | 4 | Protagonist Therapeutics, Inc (PTGX) | Sale (S): 2,712 @ $84.77 | EDGAR |
| 2025-06-11 | 4 | Protagonist Therapeutics, Inc (PTGX) | Option exercise (M): 10,000 @ $8.04 · Sale (S): 10,000 @ $55.51 · Option exercise (M): 10,000 @ $8.04 · Sale (S): 10,000 @ $57.03 · Option exercise (M): 10,000 (derivative) @ $0 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2025-03-14 | 4 | Protagonist Therapeutics, Inc (PTGX) | Option exercise (M): 28,437 @ $23.42 · Option exercise (M): 2,077 @ $38.98 · Sale (S): 30,514 @ $55.74 · Option exercise (M): 28,437 (derivative) @ $0 · Option exercise (M): 2,077 (derivative) @ $0 | EDGAR |
| 2025-01-17 | 4 | Protagonist Therapeutics, Inc (PTGX) | Sale (S): 388 @ $0 · Sale (S): 3,252 @ $0 | EDGAR |
| 2025-01-06 | 4 | Protagonist Therapeutics, Inc (PTGX) | Grant/award (A): 41,088 @ $0 · Grant/award (A): 49,862 (derivative) @ $0 | EDGAR |
| 2024-11-27 | 4 | Protagonist Therapeutics, Inc (PTGX) | Option exercise (M): 5,529 @ $8.04 · Sale (S): 5,529 @ $45.60 · Option exercise (M): 10,000 @ $8.04 · Sale (S): 10,000 @ $44.50 · Option exercise (M): 16,000 @ $8.04 · Sale (S): 16,000 @ $44.83 · +3 more | EDGAR |
| 2024-11-19 | 4 | Protagonist Therapeutics, Inc (PTGX) | Sale (S): 1,906 @ $40.98 | EDGAR |
| 2024-01-18 | 4 | Protagonist Therapeutics, Inc (PTGX) | Tax withholding (F): 427 @ $24.63 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1398940 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →